AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+19.5%
5Y CAGR+24.1%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+19.5%/yr
Annual compound
5Y CAGR
+24.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025185.16%
2024-62.23%
202354.97%
2022108.39%
2021-24.24%
202062.99%
2019-36.26%
2018-35.22%
2017110.93%
201644.73%